These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. LaPlante KL; Woodmansee S Antimicrob Agents Chemother; 2009 Sep; 53(9):3880-6. PubMed ID: 19564363 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of a Staphylococcus aureus infective endocarditis simulation model. Schwartz FA; Nielsen L; Struve Andersen J; Bock M; Christophersen L; Sunnerhagen T; Lerche CJ; Bay L; Bundgaard H; Høiby N; Moser C APMIS; 2022 Aug; 130(8):515-523. PubMed ID: 35460117 [TBL] [Abstract][Full Text] [Related]
6. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925 [TBL] [Abstract][Full Text] [Related]
7. Novel human in vitro vegetation simulation model for infective endocarditis. Schwartz FA; Christophersen L; Laulund AS; Lundquist R; Lerche C; Rude Nielsen P; Bundgaard H; Høiby N; Moser C APMIS; 2021 Nov; 129(11):653-662. PubMed ID: 34580927 [TBL] [Abstract][Full Text] [Related]
8. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure. Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090 [TBL] [Abstract][Full Text] [Related]
9. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis. Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125 [TBL] [Abstract][Full Text] [Related]
10. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates. Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance among aerobic biofilm producing bacteria isolated from chronic wounds in the tertiary care hospitals of Peshawar, Pakistan. Rahim K; Qasim M; Rahman H; Khan TA; Ahmad I; Khan N; Ullah A; Basit A; Saleha S J Wound Care; 2016 Aug; 25(8):480-6. PubMed ID: 27523661 [TBL] [Abstract][Full Text] [Related]
13. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519 [TBL] [Abstract][Full Text] [Related]
14. C-terminal deletion of RelA protein is suggested as a possible cause of infective endocarditis recurrence with Ortiz de la Rosa JM; Martín-Gutiérrez G; Casimiro-Soriguer CS; Gimeno-Gascón MA; Cisneros JM; de Alarcón A; Lepe JA Antimicrob Agents Chemother; 2024 Mar; 68(3):e0108323. PubMed ID: 38349158 [TBL] [Abstract][Full Text] [Related]
15. Bacterial biofilms in infective endocarditis: an in vitro model to investigate emerging technologies of antimicrobial cardiovascular device coatings. Lauten A; Martinović M; Kursawe L; Kikhney J; Affeld K; Kertzscher U; Falk V; Moter A Clin Res Cardiol; 2021 Mar; 110(3):323-331. PubMed ID: 32444905 [TBL] [Abstract][Full Text] [Related]
16. In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance. Dengler Haunreiter V; Boumasmoud M; Häffner N; Wipfli D; Leimer N; Rachmühl C; Kühnert D; Achermann Y; Zbinden R; Benussi S; Vulin C; Zinkernagel AS Nat Commun; 2019 Mar; 10(1):1149. PubMed ID: 30850614 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023. Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250 [TBL] [Abstract][Full Text] [Related]
18. Emerging issues on García de la Mària C; Cañas MA; Fernández-Pittol M; Dahl A; García-González J; Hernández-Meneses M; Cuervo G; Moreno A; Miró JM; Marco F Expert Rev Anti Infect Ther; 2023 Mar; 21(3):281-293. PubMed ID: 36744387 [TBL] [Abstract][Full Text] [Related]
19. Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo model. Lalanne S; Cattoir V; Guerin F; Verdier MC; Revest M J Antimicrob Chemother; 2023 Jul; 78(7):1689-1693. PubMed ID: 37248684 [TBL] [Abstract][Full Text] [Related]
20. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro. Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]